Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452594 · ClinicalTrials.gov registry record
Analysis of Diphenylcyclopropenone (DPCP) in Normals
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 30
- Enrollment target
NCT01452594 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 30 participants.
The verdict
NCT01452594 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The drug diphenylcyclopropenone, or DPCP, modifies the immune system and has been shown to be effective in treating certain kinds of cancer. This study hopes to improve our understanding of how this drug helps create an effective immune response.
Interventions
- DRUG Placebo
- DRUG Diphenylcyclopropenone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01452594
The ClinicalTrials.gov registry entry for NCT01452594 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01452594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01452594 about?
NCT01452594 is a clinical study titled "Analysis of Diphenylcyclopropenone (DPCP) in Normals". The drug diphenylcyclopropenone, or DPCP, modifies the immune system and has been shown to be effective in treating certain kinds of cancer. This study hopes to improve our understanding of how this drug helps create an effective immune response.
What is the current status of trial NCT01452594?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01452594?
The interventions under investigation include: Placebo (DRUG), Diphenylcyclopropenone (DRUG).
Who is sponsoring clinical trial NCT01452594?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.